Literature DB >> 10578150

Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the organ injury and dysfunction caused by haemorrhagic shock.

M C McDonald1, H M Filipe, C Thiemermann.   

Abstract

1 Poly (ADP-ribose) synthetase (PARS) is a nuclear enzyme activated by strand breaks in DNA, which are caused by reactive oxygen species (ROS). Here we investigate the effects of the PARS inhibitors 3-aminobenzamide (3-AB), nicotinamide and 1,5-dihydroxyisoquinoline (ISO) on the circulatory failure and the organ injury/dysfunction caused by haemorrhage and resuscitation in the anaesthetized rat. 2 Haemorrhage (sufficient to lower mean arterial blood pressure to 50 mmHg for 90 min) and subsequent resuscitation with shed blood resulted (within 4 h after resuscitation) in a delayed fall in blood pressure to 66+/-4 mmHg (control, n=13). This circulatory failure was not affected by administration (5 min prior to resuscitation) of 3-AB (10 mg kg-1 i.v., n=7), nicotinamide (10 mg kg-1 i.v., n=6) or ISO (3 mg kg-1 i.v., n=6). 3 Haemorrhage and resuscitation also resulted in rises in the serum levels of urea and creatinine. This renal dysfunction was attenuated by 3-AB and nicotinamide, but not by nicotinic acid (n=7), an inactive analogue of nicotinamide. Although ISO (n=6) also attenuated the renal dysfunction caused by haemorrhage and resuscitation, its vehicle (10% DMSO, n=4) had the same effect. 4 Haemorrhagic shock resulted in enhanced serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and lipase, indicating the development of hepatocellular and pancreatic injury, respectively. Similarly, haemorrhagic shock also resulted in an increase in the serum levels of creatine kinase (CK) indicating the development of neuromuscular injury. This was attenuated by 3-AB and nicotinamide, but not by nicotinic acid. Although ISO also attenuated the liver, pancreatic and neuromuscular injury caused by haemorrhagic shock, its vehicle had the same effect. 5 Thus, activation of PARS contributes to the organ injury and dysfunction caused by haemorrhage and resuscitation in the rat.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10578150      PMCID: PMC1571761          DOI: 10.1038/sj.bjp.0702928

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle.

Authors:  C Thiemermann; J Bowes; F P Myint; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase.

Authors:  B Zingarelli; S Cuzzocrea; Z Zsengellér; A L Salzman; C Szabó
Journal:  Cardiovasc Res       Date:  1997-11       Impact factor: 10.787

3.  Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts.

Authors:  I L Grupp; T M Jackson; P Hake; G Grupp; C Szabó
Journal:  J Mol Cell Cardiol       Date:  1999-01       Impact factor: 5.000

4.  Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia.

Authors:  M J Eliasson; K Sampei; A S Mandir; P D Hurn; R J Traystman; J Bao; A Pieper; Z Q Wang; T M Dawson; S H Snyder; V L Dawson
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

5.  3-Aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock.

Authors:  A Szabó; P Hake; A L Salzman; C Szabó
Journal:  Shock       Date:  1998-11       Impact factor: 3.454

6.  Potential role of the peroxynitrate-poly(ADP-ribose) synthetase pathway in a rat model of severe hemorrhagic shock.

Authors:  C Szabó
Journal:  Shock       Date:  1998-05       Impact factor: 3.454

7.  Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide.

Authors:  J Fan; J C Marshall; M Jimenez; P N Shek; J Zagorski; O D Rotstein
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

8.  Immunohistochemical demonstration of poly(adenosine diphosphate-ribose) synthetase in bovine tissues.

Authors:  K Ikai; K Ueda
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

9.  Inhibitors of the activity of poly (ADP-ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts.

Authors:  J Bowes; J Piper; C Thiemermann
Journal:  Br J Pharmacol       Date:  1998-08       Impact factor: 8.739

10.  Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury.

Authors:  B Zingarelli; A L Salzman; C Szabó
Journal:  Circ Res       Date:  1998-07-13       Impact factor: 17.367

View more
  5 in total

1.  Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase.

Authors:  L Liaudet; F G Soriano; E Szabó; L Virág; J G Mabley; A L Salzman; C Szabo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

2.  Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock.

Authors:  M C McDonald; H Mota-Filipe; J A Wright; M Abdelrahman; M D Threadgill; A S Thompson; C Thiemermann
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

Review 3.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

Review 4.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

5.  PARP inhibition attenuates histopathological lesion in ischemia/reperfusion renal mouse model after cold prolonged ischemia.

Authors:  Raimundo M G del Moral; Mercedes Gómez-Morales; Pedro Hernández-Cortés; David Aguilar; Trinidad Caballero; Jose Aneiros-Fernández; Mercedes Caba-Molina; M Dolores Rodríguez-Martínez; Andreina Peralta; Pablo Galindo-Moreno; Antonio Osuna; F Javier Oliver; Raimundo G del Moral; Francisco O'Valle
Journal:  ScientificWorldJournal       Date:  2013-11-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.